Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.37 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 2/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.33 |
| ▸ | MGMT | P16455 | 1/20 | 0.33 |
| ▸ | NEK2 | P51955 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29116496 | 1.00 | GDA (0.37) | GDAMKNK1CYP1A2BRAFXDH | |
| SCHEMBL31511878 | 0.82 | CYP1A2 (0.49) | GDACYP1A2BRAFXDHSMN1; SMN2 | |
| SCHEMBL29278770 | 0.82 | CYP1A2 (0.49) | GDACYP1A2BRAFXDHSMN1; SMN2 | |
| SCHEMBL29184343 | 0.80 | BRD4 (0.53) | MKNK1CYP1A2BRAFSMN1; SMN2NPC1 | |
| SCHEMBL31599206 | 0.77 | HDAC1 (0.40) | GDAMKNK1BRAFXDHSRC | |
| SCHEMBL25349258 | 0.76 | NUDT1 (0.32) | XDH | |
| SCHEMBL31360537 | 0.75 | CYP1A2 (0.35) | GDACYP1A2SMN1; SMN2CDK1CCNB1 | |
| SCHEMBL29002285 | 0.75 | CYP1A2 (0.35) | GDACYP1A2SMN1; SMN2CDK1CCNB1 | |
| SCHEMBL17372418 | 0.74 | CYP1A2 (0.46) | GDACYP1A2BRAFXDHSMN1; SMN2 | |
| SCHEMBL29638102 | 0.74 | CYP1A2 (0.46) | GDACYP1A2BRAFXDHSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119095964-A | Multi-tail and multi-cap mRNA and uses thereof | 博德研究所 | 2024-12-06 | — | — | CN | claimed |
| CN-118076741-A | Modified mRNA, modified non-coding RNA and uses thereof | 布罗德研究所股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119751285-A | Lipid compounds and lipid nanoparticle compositions | 中生复诺健生物科技(上海)有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-116829578-B | Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto | 苏州艾博生物科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119654141-A | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-117083291-B | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Delta strain | 苏州艾博生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-117069785-A | Lipid compounds and lipid nanoparticle compositions | 中生复诺健生物科技(上海)有限公司 | 2023-11-17 | — | — | CN | disclosed |
| CN-117043343-A | Nucleic acid vaccine for mutant coronaviruses | 苏州艾博生物科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-117003658-A | Lipid Nanoparticle Compositions | 苏州艾博生物科技有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116940685-A | Coronavirus multivalent nucleic acid vaccine based on sequences derived from SARS-CoV-2Beta and Delta strains | 苏州艾博生物科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116782889-A | Enhanced formulation stability and improved lyophilization process | 生物技术欧洲股份公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116670267-A | Tetravalent mRNA vaccine for influenza virus | 苏州艾博生物科技有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116472275-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-114206827-B | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-05-23 | — | — | CN | disclosed |